Sky Toyne's Journey: Overcoming Leukemia Through Transplant Innovation and Holistic Care

Diagnosis and Initial Treatment

At just 19, Sky Toyne’s life took an unexpected turn when she was diagnosed with high-risk acute myeloid leukemia (AML) during her sophomore year at college. Initially vibrant and engaged in campus life, her symptoms began subtly with headaches that escalated to severe head and neck pain, leading her to seek medical attention.

On October 7, 2021, a visit to her campus health facility revealed critically low blood counts, prompting immediate hospitalization. After a bone marrow biopsy confirmed AML, Sky learned that she faced a challenging battle. With various mutations identified, her treatment options would narrow significantly. A curative approach necessitated a stem cell transplant.

Choosing a Treatment Center

Recognizing the gravity of her situation, Sky opted for treatment at Mayo Clinic, renowned for its leadership in transplant medicine. “I decided to go to Mayo Clinic since it's the best hospital in the world and a leader in transplant,” she recalls. This decision proved pivotal as she began her journey towards recovery.

Starting with induction chemotherapy at a local hospital, she soon transferred her care to Mayo Clinic under the guidance of Dr. William Hogan, a specialist in transplant hematology. Sky felt reassured by his expertise, stating, “His expertise was astounding, and we immediately knew I was in good hands.”

Innovative Transplant Options

Sky's specific genetic profile complicated donor matching. In her case, a compatible unrelated donor wasn’t available. Instead, she needed a haploidentical transplant, which utilizes a half-matched donor—usually a family member. Thankfully, her brother Speed stepped up to be her donor. He acknowledged the gravity of the procedure but was resolute: “The decision to be the donor was an easy one. It was simply what needed to be done to give my sister a chance.”

This approach, termed haploidentical transplant, has emerged as a significant advancement in the field, expanding the donor pool and enabling more patients to find suitable matches. Dr. Hogan emphasized the importance of such innovation in making stem cell transplants accessible to a broader patient demographic.

Preventative Measures and Care Coordination

Understanding that the therapies administered during treatment could potentially impact Sky’s reproductive health, her care team engaged specialists in reproductive endocrinology to ensure her future options remained intact. “Our goal is never simply to cure leukemia — it's to help patients return to meaningful, fulfilling lives,” Dr. Hogan explained. These proactive measures underscored the holistic approach that characterized Sky’s treatment plan, taking into account not just the immediate battle against leukemia but her long-term quality of life.

On February 25, 2022, Sky underwent the transplant procedure, marking what she referred to as her “rebirthday.” The ensuing months focused not only on her physical recovery but also addressed her mental health needs, a crucial component often overlooked in similar treatments. “Transplant recovery is not just a physical process,” Dr. Hogan remarked, affirming the necessity of psychological support throughout the recovery journey.

Community Support and Personal Growth

Sky found immense support from her caregivers, particularly during challenging moments. Inspired by a nurse who had faced a similar hardships, Sky held a unique ceremony to honor her past self—complete with a flower crown and emotional eulogies from her care team and family. She described this experience as deeply meaningful, stating, “It really helped me get over my mental block.”

Sky's story resonates with the experiences of many patients navigating cancer treatment, highlighting the essential role of compassion and community in recovery. On her 100th day post-transplant, she joyously rang a bell, a symbolic celebration of her progress and remission.

Life After Treatment

Today, Sky embodies resilience and ambition, having returned to school full-time even while serving in an executive position within her sorority. Her determination saw her graduate on time in May 2024, and since then, she has gone on to earn a master’s degree and completed her first half-marathon in March 2026. “Because of advances in molecular diagnostics, targeted therapies, donor selection, transplant techniques, and supportive care, she has returned to an active, healthy life,” states Dr. Hogan, providing a testament to the transformative impact of modern medical advancements.

Reflecting on her journey, Sky remains hopeful for the future, aiming for her five-year transplant anniversary with aspirations of permanent remission. Her story exemplifies the strength of the human spirit and the profound effect of comprehensive care in the fight against leukemia, reminding us all of the importance of both medical expertise and emotional support in healing.